---
title: Garcia E, Horowitz AM, Franklin K, Mader M, Kaur S. Outcomes of veterans with
  FMS-like tyrosine kinase 3 mutated (mFLT3) acute myeloid leukemia (AML) treated
  with novel FLT3 inhibitors (FLT3i) within the Veterans Health Administration (VHA)
  [abstract]. Blood. 2023;142(suppl 1):7414
date: '2024-06-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38900483/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240620182039&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...